Ethnic differences in presentation and severity of alcoholic liver disease.

BACKGROUND The frequency of alcoholic liver disease (ALD), including alcoholic steatosis, hepatitis, and cirrhosis, varies significantly by ethnicity. METHODS With the goal to assess the role of ethnicity in determining the age of onset and severity of ALD and to compare the risk factors for its progression among ethnic groups, we conducted a retrospective chart review of all patients with ALD who were admitted or were followed as outpatients at University of California Davis Medical Center between 2002 and 2010. After excluding HBsAg- and HIV-positive subjects, we reviewed the charts of 791 patients with ALD including 130 with alcoholic fatty liver, 154 with alcoholic hepatitis, and 507 with alcoholic cirrhosis. RESULTS When controlling for all variables in the model, Hispanic patients presented at significantly 4 to 10 years younger ages than White/Caucasian patients, in each of the 3 disease severity categories, and the results were confirmed after excluding HCV Ab-/RNA-positive subjects. There were more obese Hispanic patients than White/Caucasian patients, whereas the proportion of patients with hepatitis C was significantly greater in African American subjects with alcoholic hepatitis, and the proportion of patients with diabetes mellitus was significantly lower in White/Caucasian subjects than in Hispanic subjects with cirrhosis. The proportion of subjects with severe alcoholic hepatitis was similar in Hispanic and White/Caucasian patients, but lower in African American subjects. CONCLUSIONS Ethnicity is a major factor affecting the age and severity of presentation of different subtypes of ALD.

[1]  Ryung S. Kim,et al.  Prevalence of hepatitis C virus infection in US Hispanic/Latino adults: results from the NHANES 2007-2010 and HCHS/SOL studies. , 2014, The Journal of infectious diseases.

[2]  Rohit Loomba,et al.  The global NAFLD epidemic , 2013, Nature Reviews Gastroenterology &Hepatology.

[3]  P. Friedmann Clinical practice. Alcohol use in adults. , 2013, The New England journal of medicine.

[4]  T. Zeng,et al.  Roles of Cytochrome P4502E1 Gene Polymorphisms and the Risks of Alcoholic Liver Disease: A Meta-Analysis , 2013, PloS one.

[5]  A. Panduro,et al.  Genetic polymorphisms of genes coding to alcohol-metabolizing enzymes in western Mexicans: association of CYP2E1*c2/CYP2E1*5B allele with cirrhosis and liver function. , 2012, Alcoholism, clinical and experimental research.

[6]  V. Medici,et al.  Vitamin-dependent methionine metabolism and alcoholic liver disease. , 2011, Advances in nutrition.

[7]  Hsiao-ye Yi,et al.  Alcohol-related and viral hepatitis C-related cirrhosis mortality among Hispanic subgroups in the United States, 2000-2004. , 2011, Alcoholism, clinical and experimental research.

[8]  A. Panduro,et al.  Polymorphisms of alcohol metabolizing enzymes in indigenous Mexican population: unusual high frequency of CYP2E1*c2 allele. , 2010, Alcoholism, clinical and experimental research.

[9]  David Kershenobich,et al.  Variant in PNPLA3 is associated with alcoholic liver disease , 2010, Nature Genetics.

[10]  B. Mailey,et al.  A Disease-Based Comparison of Liver Transplantation Outcomes , 2009, The American surgeon.

[11]  Gourdas Choudhuri,et al.  Polymorphism in cytochrome P450 2E1 and interaction with other genetic risk factors and susceptibility to alcoholic liver cirrhosis. , 2009, Mutation research.

[12]  C. Avellini,et al.  MTHFR C677T polymorphism and risk of HCC in patients with liver cirrhosis: role of male gender and alcohol consumption. , 2009, Alcoholism, clinical and experimental research.

[13]  Luigi Ferrucci,et al.  Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. , 2008, American journal of human genetics.

[14]  Alexander Pertsemlidis,et al.  Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease , 2008, Nature Genetics.

[15]  L. Morales,et al.  Risk Factors for Chronic Liver Disease in Blacks, Mexican Americans, and Whites in the United States: Results From NHANES IV, 1999–2004 , 2008, The American Journal of Gastroenterology.

[16]  M. Omary,et al.  Epidemiology of alcohol-related liver and pancreatic disease in the United States. , 2008, Archives of internal medicine.

[17]  Elizabeth L. Ogburn,et al.  Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. , 2007, Archives of general psychiatry.

[18]  P. Bosco,et al.  Prevalence of methylenetetrahydrofolate reductase 677T and 1298C alleles and folate status: a comparative study in Mexican, West African, and European populations. , 2006, The American journal of clinical nutrition.

[19]  L. Morales,et al.  The Health Status and Health Behaviors of Hispanics , 2006 .

[20]  Paul Zimmet,et al.  The metabolic syndrome—a new worldwide definition , 2005, The Lancet.

[21]  E. Rimm,et al.  Alcohol intake and methylenetetrahydrofolate reductase polymorphism modify the relation of folate intake to plasma homocysteine. , 2005, The American journal of clinical nutrition.

[22]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[23]  A. Barrier,et al.  The MTHFR 677C > T polymorphism is associated with an increased risk of hepatocellular carcinoma in patients with alcoholic cirrhosis. , 2004, Carcinogenesis.

[24]  S. Stewart Racial and Ethnic Differences in Alcohol-Associated Aspartate Aminotransferase and γ-Glutamyltransferase Elevation , 2002 .

[25]  S. Stewart Racial and ethnic differences in alcohol-associated aspartate aminotransferase and gamma-glutamyltransferase elevation. , 2002, Archives of internal medicine.

[26]  D. Hoyert,et al.  Social epidemiology of chronic liver disease and cirrhosis mortality in the United States, 1935-1997: trends and differentials by ethnicity, socioeconomic status, and alcohol consumption. , 2000, Human biology.

[27]  G. Ostapowicz,et al.  Role of alcohol in the progression of liver disease caused by hepatitis C virus infection , 1998, Hepatology.

[28]  K. Flegal,et al.  Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 , 1998, Diabetes Care.

[29]  G. Brandi,et al.  Drinking habits as cofactors of risk for alcohol induced liver damage , 1997, Gut.

[30]  A. Rosman,et al.  Diagnostic utility of laboratory tests in alcoholic liver disease. , 1994, Clinical chemistry.

[31]  P. Gartside,et al.  Longevity among ethnic groups in alcoholic liver disease. , 1989, Alcohol and alcoholism.

[32]  M. Salaspuro Conventional and coming laboratory markers of alcoholism and heavy drinking. , 1986, Alcoholism, clinical and experimental research.

[33]  Willis C. Maddrey,et al.  Corticosteroid therapy of alcoholic hepatitis. , 1978, Gastroenterology.